Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, United States.
Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, United States.
Int J Surg. 2017 Dec;48:166-173. doi: 10.1016/j.ijsu.2017.10.073.
Postoperative re-exploration for bleeding (RB) is a frequent complication following cardiac surgery. We aim to assess incidence, risk factors, and prognostic significance of RB in a large cohort of cardiac patients.
We reviewed prospectively collected data for all patients who underwent cardiac surgery at our institution from 2007 to 2015. Logistic regression analysis was used to identify independent predictors of RB and specific outcomes. Propensity matching using a 1:1-ratio compared outcomes of patients who had RB with patients who did not.
During the study period, 7381 patients underwent cardiac operations. Of them, 189 (2.6%) underwent RB. RB was an independent predictor of in-hospital mortality (Odds Ratio (OR):2.62 Confidence Interval (CI):1.38-4.96; p = 0.003), major adverse events (OR:3.94, CI:2.79-5.62; p < 0.001), gastrointestinal events (OR:3.54 CI:1.73-7.24), renal failure (OR:2.44, CI:1.23-4.82), prolonged ventilation (OR:3.83, CI:2.60-5.62, p < 0.001), and sepsis (OR:2.50, CI:1.03-6.04, p = 0.043). Preoperative shock (OR:3.68, CI:1.66-8.13; p = 0.001), congestive heart failure (OR:1.70 CI:1.24-2.32; p = 0.001), and urgent and emergent status (OR:2.27, CI:1.65-3.12 and OR:3.57, CI:1.89-6.75; p < 0.001 for both) were predictors of RB operative mortality. Operative mortality, incidence of major adverse events, gastrointestinal events, and respiratory failure were all significantly higher in the propensity matched RB group (p = 0.050, p < 0.001, p = 0.046, and p < 0.001 respectively).
RB significantly increases in-hospital mortality and morbidity after cardiac surgery.
心脏手术后再次探查出血(RB)是一种常见的并发症。我们旨在评估大量心脏患者中 RB 的发生率、危险因素和预后意义。
我们回顾性地收集了 2007 年至 2015 年期间在我院接受心脏手术的所有患者的前瞻性数据。使用逻辑回归分析确定 RB 的独立预测因素和特定结果。使用 1:1 比例的倾向匹配比较有 RB 与无 RB 患者的结果。
在研究期间,7381 名患者接受了心脏手术。其中,189 名(2.6%)患者接受了 RB。RB 是院内死亡率的独立预测因素(优势比(OR):2.62,置信区间(CI):1.38-4.96;p=0.003)、主要不良事件(OR:3.94,CI:2.79-5.62;p<0.001)、胃肠道事件(OR:3.54,CI:1.73-7.24)、肾功能衰竭(OR:2.44,CI:1.23-4.82)、延长通气(OR:3.83,CI:2.60-5.62,p<0.001)和败血症(OR:2.50,CI:1.03-6.04,p=0.043)。术前休克(OR:3.68,CI:1.66-8.13;p=0.001)、充血性心力衰竭(OR:1.70,CI:1.24-2.32;p=0.001)和紧急状态(OR:2.27,CI:1.65-3.12 和 OR:3.57,CI:1.89-6.75;p<0.001)是 RB 手术死亡率的预测因素。在倾向性匹配的 RB 组中,手术死亡率、主要不良事件、胃肠道事件和呼吸衰竭的发生率均显著升高(p=0.050,p<0.001,p=0.046,p<0.001)。
RB 显著增加心脏手术后的住院死亡率和发病率。